Centene Corporation

CNC Healthcare Healthcare Plans

Centene Corporation’s revenue for fiscal 2025 (year ended December 2025) was $194.8 billion, up 19.4% from fiscal 2024.

Revenue
+1.93%
EPS
+99.0%
Free cash flow
−437.4%
Total debt
−11.6%

Quarter to September 2026, against a year earlier

66.49 1.96 −2.86%
Market cap
$32.9B
P/E
22.4×
Fwd P/E
17.4×
Dividend yield
—
F-score
5/9
Altman Z
2.64
Beneish M
−3.07
Dividend safety
n/a

Centene Corporation 10-Q filed Oct 27, 2026

Fiscal Q3 2026 · Period ended Sep 30, 2026 · Filed · accepted 7:03 PM ET · Document on sec.gov · Filing index

What changed

Part I, Item 2, Management’s Discussion and Analysis, against the 10-Q filed Jul 28, 2026: 18 added · 7 removed · 48 modified; 30 with only figures updated; 2 moved without change

  1. Modified · General

    We are a leading healthcare enterprise that is committed to helping people live healthier lives. The Company takes a local approach with local teams to provide fully integrated, high-quality and cost-effective services to government-sponsored and commercial healthcare programs, focusing on under-insured and uninsured individuals. Centene offers affordable and high-quality products to more than 1 in 15 individuals across the nation, including Medicaid and Medicare members (including Medicare Prescription Drug Plans (PDPs)) as well as individuals and families served by the Health Insurance Marketplace.

72 more changes in this Item, word by word, in Powerpack.